ABSENCE OF A PROMOTING OR SEQUENTIAL SYNCARCINOGENIC EFFECT IN RAT-LIVER BY THE CARCINOGENIC HYPOLIPIDEMIC DRUG NAFENOPIN GIVEN AFTER N-2-FLUORENYLACETAMIDE

被引:24
作者
NUMOTO, S [1 ]
MORI, H [1 ]
FURUYA, K [1 ]
LEVINE, WG [1 ]
WILLIAMS, GM [1 ]
机构
[1] AMER HLTH FDN,NAYLOR DANA INST DIS PREVENT,VALHALLA,NY 10595
关键词
D O I
10.1016/0041-008X(85)90269-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:76 / 85
页数:10
相关论文
共 48 条
[1]   INCORPORATION OF RADIOACTIVITY FROM LABELED DI-(2-ETHYLHEXYL)PHTHALATE INTO DNA OF RAT-LIVER INVIVO [J].
ALBRO, PW ;
CORBETT, JT ;
SCHROEDER, JL ;
JORDAN, ST .
CHEMICO-BIOLOGICAL INTERACTIONS, 1983, 44 (1-2) :1-16
[2]   STUDIES ON HEPATOMEGALY CAUSED BY HYPOLIPIDEMIC DRUGS NAFENOPIN AND CLOFIBRATE [J].
BECKETT, RB ;
CENEDELLA, RJ ;
WEISS, R ;
STITZEL, RE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1972, 23 (01) :42-+
[3]   LIPID EFFECTS OF A PHENOLIC ETHER (SU-13437) IN RAT - COMPARISON WITH CPIB [J].
BEST, MM ;
DUNCAN, CH .
ATHEROSCLEROSIS, 1970, 12 (02) :185-&
[4]  
BLANE GF, 1980, NOUV PRESSE MED, V9, P3737
[5]  
FITZGERALD JE, 1981, J NATL CANCER I, V67, P1105
[6]  
FURUKAWA K, 1984, CHEM-BIOL INTERACT, V48, P43, DOI 10.1016/0009-2797(84)90005-X
[7]   AN ENHANCING EFFECT OF THE ANTIHISTAMINIC DRUG METHAPYRILENE ON RAT-LIVER CARCINOGENESIS BY PREVIOUSLY ADMINISTERED N-2-FLUORENYLACETAMIDE [J].
FURUYA, K ;
MORI, H ;
WILLIAMS, GM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1983, 70 (01) :49-56
[8]   NEOPLASTIC CONVERSION IN RAT-LIVER BY THE ANTIHISTAMINE METHAPYRILENE DEMONSTRATED BY A SEQUENTIAL SYNCARCINOGENIC EFFECT WITH N-2-FLUORENYLACETAMIDE [J].
FURUYA, K ;
WILLIAMS, GM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1984, 74 (01) :63-69
[9]   DETECTION OF PEROXISOMAL FATTY ACYL-COENZYME-A OXIDASE ACTIVITY [J].
INESTROSA, NC ;
BRONFMAN, M ;
LEIGHTON, F .
BIOCHEMICAL JOURNAL, 1979, 182 (03) :779-788
[10]   STRUCTURE, COMPOSITION, PHYSICAL-PROPERTIES, AND TURNOVER OF PROLIFERATED PEROXISOMES - STUDY OF TROPHIC EFFECTS OF SU-13437 ON RAT-LIVER [J].
LEIGHTON, F ;
COLOMA, L ;
KOENIG, C .
JOURNAL OF CELL BIOLOGY, 1975, 67 (02) :281-309